1. HOME
  2. ABOUT US
    About Laekna Management Team Milestones Honors &
    Awards
  3. R&D
    R&D Therapeutic Areas Core Products Pipeline Clinical Trials
  4. PARTNERSHIPS
    Strategic Partners Business Development BD Contact
  5. INVESTORS
    Investors IR Contact
  6. NEWS
    Press Releases Media Coverage
  7. CAREERS
    Team Structure Career Development Jobs My Laekna
  8. CONTACT US
    Contact Us Leave Message
  9. RSS Feeds
 ABOUT US
Ground-breaking THERAPEUTICS

Founded in December 2016, we are an emerging 

innovative biotech company based in

Shanghai, China and New Jersey, USA

Aiming for First-in-Class and Best-in-Class drugs

Learn More
GMP Production Plant
Lingang, Shanghai
R&D Centers
Zhangjiang Pharma Valley, Shanghai, China
New Jersey, USA
 ABOUT US
CUTTING-EDGE THERAPEUTICS

Founded in December 2016, we are an emerging 

innovative biotech company based in

Shanghai, China and New Jersey, USA

Aiming for First-in-Class and Best-in-Class drugs

Learn More
R&D Centers
Zhangjiang Pharma Valley, Shanghai, China
New Jersey, USA
GMP Production Plant
Lingang, Shanghai
R&D
LEADING INNOVATION

Focused on developing

groundbreaking innovative

therapies to treat cancer and liver diseases


More in the pipeline

  1. 4

    drug candidates with global License

    in-licensed from Novartis


  2. 2

    drug candidate in registrational

    phase II


  3. 1

    drug candidate in

    phase II


  4. 3

    drug candidates in

    phase I


  5. 10+

    drug candidates in

    preclinical stages


NEWS
LATEST ARTICLES
Learn More
  1. 2021-12-23
    Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase
    More
  2. 2021-10-19
    Laekna hits the headlines during Shanghai International Biopharma Industry Week 2021
    More
  3. 2021-09-16
    Laekna Therapeutics reported positive results in two clinical studies for the treatment of various stages of prostate cancer at the ESMO Congress
    Learn More
    2021-08-26
    Laekna Therapeutics receives IND approvals in China and US for phase Ib/III global multi-center clinical study of afuresertib in combination with fulvestrant for patients with hr+/her2- breast cancer
    Learn More
    2021-07-26
    Laekna Therapeutics will present two clinical study results in ESMO 2021
    Learn More
NEWS
LATEST ARTICLES
Learn More
  1. Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase
    2021-12-23
    Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase
    More
  2. 2021-10-19
    Laekna hits the headlines during Shanghai International Biopharma Industry Week 2021
    More
  3. 2021-09-16
    Laekna Therapeutics reported positive results in two clinical studies for the treatment of various stages of prostate cancer at the ESMO Congress
    More
CAREERS
OUR PEOPLE
Join Us
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
  1. Name*
  2. Email*
  3. Company
  4. Occupation

News

Positions

Follow us on Linkedin

  1. HOME
  2. ABOUT US
  3. R&D
  4. PARTNERSHIPS
  5. INVESTORS
  6. NEWS
  7. CAREERS
  8. CONTACT US

Copyright © Laekna Therapeutics, All Rights Reserved.  Privacy Policy

Follow us on Linkedin

Follow us on Wechat